JPS604938B2 - 免疫学的試薬及びその使用方法 - Google Patents
免疫学的試薬及びその使用方法Info
- Publication number
- JPS604938B2 JPS604938B2 JP51007067A JP706776A JPS604938B2 JP S604938 B2 JPS604938 B2 JP S604938B2 JP 51007067 A JP51007067 A JP 51007067A JP 706776 A JP706776 A JP 706776A JP S604938 B2 JPS604938 B2 JP S604938B2
- Authority
- JP
- Japan
- Prior art keywords
- polyethylene glycol
- immunological
- weight
- antibody
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 91
- 230000001900 immune effect Effects 0.000 title claims description 21
- 229920001223 polyethylene glycol Polymers 0.000 claims description 65
- 239000002202 Polyethylene glycol Substances 0.000 claims description 64
- 239000000203 mixture Substances 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 47
- 239000000243 solution Substances 0.000 claims description 46
- 239000002736 nonionic surfactant Substances 0.000 claims description 36
- 238000003556 assay Methods 0.000 claims description 31
- 239000000427 antigen Substances 0.000 claims description 26
- 102000036639 antigens Human genes 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 238000004458 analytical method Methods 0.000 claims description 17
- 238000010324 immunological assay Methods 0.000 claims description 17
- -1 polyoxypropylene Polymers 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 238000000149 argon plasma sintering Methods 0.000 claims description 11
- 229920001400 block copolymer Polymers 0.000 claims description 11
- 229920001451 polypropylene glycol Polymers 0.000 claims description 9
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000003018 immunoassay Methods 0.000 claims description 8
- 108060003951 Immunoglobulin Proteins 0.000 claims description 7
- 102000018358 immunoglobulin Human genes 0.000 claims description 7
- 229940072221 immunoglobulins Drugs 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 5
- 229920005862 polyol Polymers 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 238000004848 nephelometry Methods 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000005228 aryl sulfonate group Chemical group 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 description 18
- 239000000523 sample Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 229920001983 poloxamer Polymers 0.000 description 12
- 238000003127 radioimmunoassay Methods 0.000 description 11
- 239000002245 particle Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 7
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 6
- 102000004338 Transferrin Human genes 0.000 description 6
- 108090000901 Transferrin Proteins 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000012581 transferrin Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920002012 Pluronic® F 38 Polymers 0.000 description 4
- 229920002359 Tetronic® Polymers 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 238000007817 turbidimetric assay Methods 0.000 description 4
- 102000016918 Complement C3 Human genes 0.000 description 3
- 108010028780 Complement C3 Proteins 0.000 description 3
- 102000006771 Gonadotropins Human genes 0.000 description 3
- 108010086677 Gonadotropins Proteins 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 229920002257 Plurafac® Polymers 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002622 gonadotropin Substances 0.000 description 3
- 125000001165 hydrophobic group Chemical group 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 2
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000760 immunoelectrophoresis Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- 101710081722 Antitrypsin Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 102000014702 Haptoglobin Human genes 0.000 description 1
- 108050005077 Haptoglobin Proteins 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000001475 anti-trypsic effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940094892 gonadotropins Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54506675A | 1975-01-29 | 1975-01-29 | |
| US545066 | 1975-01-29 | ||
| US55590875A | 1975-03-06 | 1975-03-06 | |
| US555908 | 1975-03-06 | ||
| US05/615,024 US4148869A (en) | 1975-03-06 | 1975-09-19 | Immunological reagent and method of using same |
| US615024 | 1975-09-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS51101121A JPS51101121A (enExample) | 1976-09-07 |
| JPS604938B2 true JPS604938B2 (ja) | 1985-02-07 |
Family
ID=27415448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51007067A Expired JPS604938B2 (ja) | 1975-01-29 | 1976-01-23 | 免疫学的試薬及びその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS604938B2 (enExample) |
| BE (1) | BE837675A (enExample) |
| BR (1) | BR7600322A (enExample) |
| CA (1) | CA1080619A (enExample) |
| CH (1) | CH613047A5 (enExample) |
| DE (2) | DE2602068C2 (enExample) |
| DK (1) | DK150809C (enExample) |
| ES (1) | ES444543A1 (enExample) |
| FR (1) | FR2299645A1 (enExample) |
| GB (1) | GB1540097A (enExample) |
| IL (1) | IL48804A (enExample) |
| IT (1) | IT1062433B (enExample) |
| NL (1) | NL183852C (enExample) |
| NO (1) | NO149864C (enExample) |
| SE (1) | SE441392B (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990004179A1 (fr) * | 1988-10-13 | 1990-04-19 | Nippon Oil And Fats Co., Ltd. | Procede d'analyse d'une substance immunologiquement active et reactif utilise |
| EP0532757A4 (en) * | 1991-01-10 | 1993-11-24 | Teijin Limited | Highly sensitive assay of tissue factor and kit therefor |
| JP2014206391A (ja) * | 2013-04-10 | 2014-10-30 | 積水メディカル株式会社 | ラテックス免疫凝集測定試薬 |
| EP3882631A4 (en) * | 2018-11-09 | 2022-08-24 | Sekisui Medical Co., Ltd. | METHOD OF SUPPRESSING ABNORMAL DETECTION IN IMMUNOASSAY BY AUTOMATIC ANALYZER AND IMMUNOASSAY REAGENT |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2901327B1 (de) * | 1979-01-15 | 1980-07-24 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung eines opsonierenden oberflaechenbindenden alpha?-Glykoproteins |
| FI792576A7 (fi) * | 1979-08-20 | 1981-01-01 | Orion Yhtymae Oy | Parannettu entsyymi-immunologinen määritysmenetelmä. |
| JPS5943362A (ja) * | 1982-09-06 | 1984-03-10 | Kainosu:Kk | 免疫学的測定試薬 |
| AU580248B2 (en) * | 1982-10-13 | 1989-01-12 | Biowhittaker Technologies, Inc. | Fluorometric assay of allergic reactions and reagents therefor |
| GB8317855D0 (en) * | 1983-06-30 | 1983-08-03 | Iq Bio Ltd | Biochemical detection method |
| DE3327642A1 (de) * | 1983-07-30 | 1985-02-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung eines partners einer immunreaktion sowie reagens zur durchfuehrung dieses verfahrens |
| DE3532626A1 (de) * | 1985-09-12 | 1987-03-19 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung eines partners einer immunreaktion |
| JPS62159047A (ja) * | 1985-12-31 | 1987-07-15 | Chemo Sero Therapeut Res Inst | 血漿蛋白定量用試薬 |
| US4810638A (en) * | 1986-07-24 | 1989-03-07 | Miles Inc. | Enzyme-labeled antibody reagent with polyalkyleneglycol linking group |
| EP0642665A4 (en) * | 1993-03-26 | 1997-05-02 | Curative Tech Inc | METHOD AND ASSAY INCLUDING IMPROVED BINDING REACTIVITY OF A POLYPEPTIDE. |
| US7811601B2 (en) | 2003-04-03 | 2010-10-12 | Seed Co., Ltd. | Ophthalmic lenses capable of sustained drug release and preservative solutions therefor |
| JP4915638B2 (ja) * | 2005-08-26 | 2012-04-11 | パナソニック株式会社 | 無電極放電灯装置及びこの無電極放電灯装置を備えた照明器具 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1598151A1 (de) * | 1966-11-19 | 1970-05-27 | Kleine Dr Rer Nat Norbert | Agglutinationsverstaerker |
| DE2361169C3 (de) * | 1973-12-07 | 1978-09-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur Aktivierung von von Detengensspuren befreiter Cholesterinoxydase |
| US3947250A (en) * | 1974-06-21 | 1976-03-30 | Baxter Laboratories, Inc. | Method of immunodiffusion |
-
1976
- 1976-01-07 IL IL48804A patent/IL48804A/xx unknown
- 1976-01-12 SE SE7600232A patent/SE441392B/xx not_active IP Right Cessation
- 1976-01-12 CA CA243,325A patent/CA1080619A/en not_active Expired
- 1976-01-15 FR FR7600986A patent/FR2299645A1/fr active Granted
- 1976-01-16 GB GB1784/76A patent/GB1540097A/en not_active Expired
- 1976-01-16 DK DK016976A patent/DK150809C/da not_active IP Right Cessation
- 1976-01-16 IT IT19348/76A patent/IT1062433B/it active
- 1976-01-19 BR BR7600322A patent/BR7600322A/pt unknown
- 1976-01-19 BE BE163598A patent/BE837675A/xx not_active IP Right Cessation
- 1976-01-21 DE DE2602068A patent/DE2602068C2/de not_active Expired
- 1976-01-21 DE DE2661010A patent/DE2661010C2/de not_active Expired
- 1976-01-22 NO NO760203A patent/NO149864C/no unknown
- 1976-01-22 ES ES444543A patent/ES444543A1/es not_active Expired
- 1976-01-23 NL NLAANVRAGE7600697,A patent/NL183852C/xx not_active IP Right Cessation
- 1976-01-23 JP JP51007067A patent/JPS604938B2/ja not_active Expired
- 1976-01-27 CH CH102276A patent/CH613047A5/xx not_active IP Right Cessation
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990004179A1 (fr) * | 1988-10-13 | 1990-04-19 | Nippon Oil And Fats Co., Ltd. | Procede d'analyse d'une substance immunologiquement active et reactif utilise |
| EP0532757A4 (en) * | 1991-01-10 | 1993-11-24 | Teijin Limited | Highly sensitive assay of tissue factor and kit therefor |
| JP2014206391A (ja) * | 2013-04-10 | 2014-10-30 | 積水メディカル株式会社 | ラテックス免疫凝集測定試薬 |
| EP3882631A4 (en) * | 2018-11-09 | 2022-08-24 | Sekisui Medical Co., Ltd. | METHOD OF SUPPRESSING ABNORMAL DETECTION IN IMMUNOASSAY BY AUTOMATIC ANALYZER AND IMMUNOASSAY REAGENT |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7600697A (nl) | 1976-08-02 |
| JPS51101121A (enExample) | 1976-09-07 |
| IL48804A (en) | 1979-05-31 |
| DE2602068A1 (de) | 1976-08-05 |
| NO149864C (no) | 1984-07-04 |
| NL183852B (nl) | 1988-09-01 |
| NO760203L (enExample) | 1976-07-30 |
| BE837675A (fr) | 1976-07-19 |
| DK150809C (da) | 1988-05-02 |
| DK16976A (da) | 1976-07-30 |
| NL183852C (nl) | 1989-02-01 |
| DK150809B (da) | 1987-06-22 |
| IT1062433B (it) | 1984-10-10 |
| IL48804A0 (en) | 1976-03-31 |
| DE2661010C2 (de) | 1987-03-19 |
| DE2602068C2 (de) | 1986-09-11 |
| CA1080619A (en) | 1980-07-01 |
| ES444543A1 (es) | 1977-06-01 |
| FR2299645B1 (enExample) | 1980-11-28 |
| SE441392B (sv) | 1985-09-30 |
| SE7600232L (sv) | 1976-07-30 |
| BR7600322A (pt) | 1976-08-31 |
| GB1540097A (en) | 1979-02-07 |
| NO149864B (no) | 1984-03-26 |
| FR2299645A1 (fr) | 1976-08-27 |
| CH613047A5 (en) | 1979-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS604938B2 (ja) | 免疫学的試薬及びその使用方法 | |
| US4174952A (en) | Immunoassay by light scattering intensity anisotropy measurements | |
| US4450231A (en) | Immunoassay for determination of immune complexes with polymer-coated plastic base | |
| SU1554782A3 (ru) | Способ определени антигенов или антител | |
| CN109470865B (zh) | 免疫测定方法、用于鉴定免疫测定的系统和试剂盒 | |
| EP0516529A2 (en) | Assay of specific antibody | |
| JP4577747B2 (ja) | 免疫学的測定法用凝集促進剤 | |
| JPS605899B2 (ja) | 免疫化学的定量法 | |
| Nishikawa et al. | Competitive nephelometric immunoassay of theophylline in plasma | |
| JPH01301165A (ja) | 免疫測定法 | |
| JPS61280568A (ja) | 体液成分の測定方法 | |
| US6927071B2 (en) | Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma | |
| EP0439611B1 (en) | Method for assaying immunologically active substance and reagent therefor | |
| US7202041B2 (en) | Immunoreaction measurement method | |
| CN116068183A (zh) | 一种免疫测定方法及其应用 | |
| FI76216B (fi) | Bestaemningsfoerfarande foer antigen. | |
| JPS6113135A (ja) | 反応相手の測定法およびそのための装置 | |
| JPH08292192A (ja) | 免疫測定法 | |
| CN111896756A (zh) | 一种用于测定游离甲状腺素的试剂盒 | |
| US3955923A (en) | Serologic reaction method | |
| JPS6312960A (ja) | 免疫学的試験用水性溶媒 | |
| JP2931111B2 (ja) | 癌診断剤 | |
| JP2001074739A (ja) | 免疫学的測定方法、免疫反応干渉物質の除去方法および測定試薬 | |
| Koelle et al. | Comparison of a fluorometric method with radial immunodiffusion assays for determination of complement components C3 and C4 | |
| JPH0389166A (ja) | 抗体活性の測定方法 |